Search Results | Blood | American Society of Hematology

1-20 of 60

2 3

Sort by

Sort Order Select

Journal Articles

Multiple TET2 Mutations As a New Biological Clue for Differentiating Oligomonocytic Chronic Myelomonocytic Leukemia from Myelodysplastic Syndromes

Nieves Garcia-Gisbert, Leonor Arenillas, David Roman-Bravo, Juan José Rodríguez-Sevilla, Brayan Merchan, Sara Garcia-Avila, Concepción Fernández-Rodríguez, Joan Gibert, Antonio Salar, Beatriz Bellosillo, Ana Ferrer, Xavier Calvo

Blood (2021) 138 (Supplement 1): 1530.

DOI: https://doi.org/10.1182/blood-2021-152674

Published: 2021

Journal Articles

Clinical Outcomes of Oligomonocytic Chronic Myelomonocytic Leukemia (OM-CMML) and Predictive Factors of Evolution of OM-CMML into Overt Chronic Myelomonocytic Leukemia (CMML)

David Roman-Bravo, Leonor Arenillas, Maria Teresa Asensi, Nieves Garcia-Gisbert, Juan Jose Rodriguez-Sevilla, Brayan Merchan, Sara García Ávila, Beatriz Bellosillo, Concepción Fernández-Rodríguez, Lourdes Florensa, Ana Ferrer, Xavier Calvo

Blood (2021) 138 (Supplement 1): 1533.

DOI: https://doi.org/10.1182/blood-2021-146447

Published: 2021

Journal Articles

Overactivation of the NLRP3 Inflammasome in Chronic Myelomonocytic Leukemia KRAS Mutated Patients Can be Detected By the Apoptosis-Associated Speck-like Protein (ASC) and Reverted By IL1β Inhibitors

Blood (2021) 138 (Supplement 1): 3670.

DOI: https://doi.org/10.1182/blood-2021-153686

Published: 2021

Journal Articles

Clonal Dynamics of JAK2 V617F and Non-Driver Mutations in Polycythemia Vera and Essential Thrombocythemia Patients Receiving Hydroxyurea Therapy

Lierni Fernández-Ibarrondo, Joan Gibert, Concepción Fernández-Rodríguez, Laura Camacho, Anna Angona, Marcio Andrade, Nieves Garcia-Gisbert, Leonor Arenillas, Patricia Vélez, Raquel Longarón, Ramon Diez-Feijoo, Antonio Salar, Carles Besses, Beatriz Bellosillo

Blood (2021) 138 (Supplement 1): 3623.

DOI: https://doi.org/10.1182/blood-2021-150491

Published: 2021

Journal Articles

Low-Risk Polycythemia Vera Treated with Phlebotomies: Clinical Characteristics, Hematologic Control and Complications in 358 Patients from the Spanish Registry of Polycythemia Vera

Blood (2021) 138 (Supplement 1): 3621.

DOI: https://doi.org/10.1182/blood-2021-145012

Published: 2021

Journal Articles

Non-Invasive Genetic Profiling and Monitoring in Myelodysplastic Syndromes

Nieves Garcia-Gisbert, Brayan Merchan, Sara Garcia-Avila, Marta Salido, Concepción Fernández-Rodríguez, Joan Gibert, Lierni Fernández-Ibarrondo, Laura Camacho, Marta Lafuente, Raquel Longarón, Blanca Espinet, Patricia Vélez, Marcio M Andrade-Campos, Ramon M. Pujol, Leonor Arenillas, Xavier Calvo, Carles Besses, Antonio Salar, Beatriz Bellosillo

Blood (2021) 138 (Supplement 1): 2599.

DOI: https://doi.org/10.1182/blood-2021-148297

Published: 2021

Journal Articles

Hydroxyurea Reduces Neutrophil Extracellular Trap Formation in Myeloproliferative Neoplasms

Ernesto J Cuenca, Nieves García Gisbert, BSc, Ascensión M de Los Reyes-García, PhDStudent, Cristina Aroca, MD, Lorena Martinez-Montesinos, MD, Marcio Andrade, MD PhD, Sonia Aguila, PhD, Pedro J Guijarro-Carrillo, Rosa Cifuentes-Riquelme, PhDStudent, Rocio González-Conejero, PhD, Constantino Martínez, PhD, Vicente Vicente, MD PhD, Alberto Alvarez-Larrán, MD, Beatriz Bellosillo, PhD, Raul Teruel-Montoya, PhD, Francisca Ferrer Marin, MD PhD

Blood (2020) 136 (Supplement 1): 20–21.

DOI: https://doi.org/10.1182/blood-2020-139368

Published: 2020

Journal Articles

Molecular Characterization and Clinical Outcomes of Young Adult Patients (≤45 years old) with Philadelphia-Negative Myeloproliferative Neoplasms

Marcio M Andrade-Campos, MD PhD, Lierni Fernández-Ibarrondo, Joan Gibert, PhD, Concepción Fernández, Brayan Merchan, MD, Nieves García Gisbert, BSc, Laura Camacho, Leonor Arenillas, MD PhD, Sara García Ávila, MD, Raquel Longarón, Antonio Salar, MD PhD, Carles Besses, MD PhD, Beatriz Bellosillo, PhD

Blood (2020) 136 (Supplement 1): 13–14.

DOI: https://doi.org/10.1182/blood-2020-142705

Published: 2020

Journal Articles

Assessment of Cell-Free DNA (cfDNA) in 221 Patients with Lymphoproliferative Malignancies at Diagnosis and during Follow-up

Marcio M Andrade-Campos, MD PhD, Antonio Salar, MD PhD, Blanca Sanchez-Gonzalez, MD, Concepción Fernández-Rodríguez, Eva Gimeno, MD PhD, L Ruiz, Gabriel Piquer, Francesc Garcia-Pallarols, BSc, Natalia Papaleo, MD, Ivonne Vazquez, Lluís Colomo, MD PhD, Beatriz Bellosillo, PhD

Blood (2019) 134 (Supplement_1): 492.

DOI: https://doi.org/10.1182/blood-2019-131081

Published: 2019

Journal Articles

High Diagnostic Utility of Flow Cytometry Based Peripheral Blood Monocyte Subset Analysis, CD56 and CD2 Expression in Chronic Myelomonocytic Leukemia (CMML)

Xavier Calvo, MD PhD, Ivonne Parraga, Fellow, Nieves Garcia-Gisbert, MSc, Lourdes Florensa, MD PhD, Sara Montesdeoca, MD, Concepción Fernández, Marta Salido, PhD, Anna Puiggros, PhD, Blanca Espinet, PhD, Beatriz Bellosillo, PhD, Lluís Colomo, MD PhD, David Roman, MD, Marcio Andrade Campos, MD PhD, Brayan Merchan, MD MSc, Ana Ferrer, MD PhD, Leonor Arenillas, MD PhD

Blood (2019) 134 (Supplement_1): 5437.

DOI: https://doi.org/10.1182/blood-2019-130499

Published: 2019

Journal Articles

Clinical Characteristics and Cardioavscular Events in Patients with Esential Thrombocythemia with <10% Vs. ≥10% JAK2 V617F Allele Burden

Blood (2019) 134 (Supplement_1): 4171.

DOI: https://doi.org/10.1182/blood-2019-126980

Published: 2019

Journal Articles

Oligomonocytic Chronic Myelomonocytic Leukemia (O-CMML) and Chronic Myelomonocytic Leukemia (CMML) Show Similar Clinical, Morphological, Immunophenotypic and Molecular Features

Xavier Calvo, MD PhD, Nieves Garcia-Gisbert, MSc, Ivonne Parraga, Fellow, Lourdes Florensa, MD PhD, Sara Montesdeoca, MD, Concepción Fernández, Marta Salido, PhD, Anna Puiggros, PhD, Blanca Espinet, PhD, Beatriz Bellosillo, PhD, Lluís Colomo, MD PhD, David Roman, MD, Marcio Andrade, MD PhD, Brayan Merchan, MD MSc, Ana Ferrer, MD PhD, Leonor Arenillas, MD PhD

Blood (2019) 134 (Supplement_1): 4266.

DOI: https://doi.org/10.1182/blood-2019-130445

Published: 2019

Journal Articles

Molecular Characterization of Ph-Negative Myeloproliferative Neoplasms in Tumor Circulating Nucleic Acids

Nieves Garcia-Gisbert, MSc, Lierni Fernández-Ibarrondo, Concepción Fernández-Rodríguez, Laura Camacho, Anna Angona, MD PhD, Joan Gibert, PhD, Xavier Calvo, MD PhD, Leonor Arenillas, MD PhD, Raquel Longarón, Marcio Andrade, MD PhD, Antonio Salar, MD PhD, Carles Besses, MD PhD, Beatriz Bellosillo, PhD

Blood (2019) 134 (Supplement_1): 2953.

DOI: https://doi.org/10.1182/blood-2019-123003

Published: 2019

Journal Articles

rs2431697, a Polymorphism of Mir-146a, Is a Precozing Marker of Progression to Secondary Myelofibrosis: New Epigenetic Regulation of Jak/Stat3 Signaling

Blood (2018) 132 (Supplement 1): 3072.

DOI: https://doi.org/10.1182/blood-2018-99-119221

Published: 2018

Journal Articles

Acquisition of Non-Driver Mutations during Follow-up in Patients with Polycythemia Vera and Essential Thrombocythemia

Alicia Senín, Concepción Fernández Rodríguez, Beatriz Bellosillo, Laura Camacho, Lierni Fernández, Raquel Longarón, Anna Angona, Carlos Besses Raebel, MD PhD, Alberto Alvarez Larran

Blood (2017) 130 (Supplement 1): 2937.

DOI: https://doi.org/10.1182/blood.V130.Suppl_1.2937.2937

Published: 2017

Journal Articles

Role of Non-Driver Mutations and JAK2 V617F Allele Burden in Myelofibrotic and Acute Myeloid Transformation of Patients with Polycythemia Vera and Essential Thrombocythemia

Alicia Senín, Conchi Fernández, Beatriz Bellosillo, PhD, Laura Camacho, Raquel Longaron, Anna Angona, Sara Montesdeoca, Carlos Besses, Alberto Alvarez-Larrán

Blood (2016) 128 (22): 1952.

DOI: https://doi.org/10.1182/blood.V128.22.1952.1952

Published: 2016

Journal Articles

Potential of Digital PCR in CML Calibration

Niels Pallisgaard, Morten T. Andersen, Anni Aggerholm, PhD, Hans Ehrencrona, MD PhD, Beatriz Bellosillo, Elisabeth Oppliger Leibundgut, PharmD

Blood (2014) 124 (21): 1817.

DOI: https://doi.org/10.1182/blood.V124.21.1817.1817

Published: 2014

Journal Articles

MYD88 (L265P) Mutation Confers Very Poor Response and Outcome after Second-Line Therapy in Patients with Diffuse Large B-Cell Lymphoma (DLBCL)

Antonio Salar, MD, Francesc Garcia-Pallarols, BsC, Concepcion Fernández-Rodríguez, Blanca Sánchez-González, MD, Mari Carmen Vela, Eva Gimeno, Silvia Pairet, Alicia Senin, Laura Camacho, Sergi Serrano, MD PhD, Carlos Besses, Beatriz Bellosillo

Blood (2014) 124 (21): 1690.

DOI: https://doi.org/10.1182/blood.V124.21.1690.1690

Published: 2014

Journal Articles

Characterization of CD34+ Hematopoietic Progenitor Cells in JAK2 V617F and Calr- mutated Myeloproliferative Neoplasms

Anna Angona, Alberto Alvarez, Raquel Longarón, Laura Camacho, Concepción Fernández, Silvia Pairet, Luz Martinez, Agueda Ancochea, Alicia Senin, Beatriz Bellosillo, Carlos Besses

Blood (2014) 124 (21): 4572.

DOI: https://doi.org/10.1182/blood.V124.21.4572.4572

Published: 2014

Journal Articles

JAK2 Exon 12 Mutant Allele Burden Study (JETMABS): A European Multicenter Study

Lasse Kjaer, Ph.D., Eric Lippert, Francois Girodon, MD, PhD, Susanne Schnittger, PhD, Serge Carillo, Caroline Riley, MD, Beatriz Bellosillo, Maj K. Westman, Ole Weis Bjerrum, MD, Marzena Wojtaszewska, Thomas Kristensen, MSc, PhD, Melanie Percy, PhD, Mary Frances McMullin, MD, MRCPath, Maruska Marusic, Caroline Rosmond, Lars Palmqvist, MD, PhD, Sylvie Hermouet, MD, Ph.D., Hans Carl Hasselbalch, MD, DMSc

Blood (2013) 122 (21): 4075.

DOI: https://doi.org/10.1182/blood.V122.21.4075.4075

Published: 2013

2 3

NARROW

Multiple TET2 Mutations As a New Biological Clue for Differentiating Oligomonocytic Chronic Myelomonocytic Leukemia from Myelodysplastic Syndromes

Clinical Outcomes of Oligomonocytic Chronic Myelomonocytic Leukemia (OM-CMML) and Predictive Factors of Evolution of OM-CMML into Overt Chronic Myelomonocytic Leukemia (CMML)

Overactivation of the NLRP3 Inflammasome in Chronic Myelomonocytic Leukemia KRAS Mutated Patients Can be Detected By the Apoptosis-Associated Speck-like Protein (ASC) and Reverted By IL1β Inhibitors

Clonal Dynamics of JAK2 V617F and Non-Driver Mutations in Polycythemia Vera and Essential Thrombocythemia Patients Receiving Hydroxyurea Therapy

Low-Risk Polycythemia Vera Treated with Phlebotomies: Clinical Characteristics, Hematologic Control and Complications in 358 Patients from the Spanish Registry of Polycythemia Vera

Non-Invasive Genetic Profiling and Monitoring in Myelodysplastic Syndromes

Hydroxyurea Reduces Neutrophil Extracellular Trap Formation in Myeloproliferative Neoplasms

Molecular Characterization and Clinical Outcomes of Young Adult Patients (≤45 years old) with Philadelphia-Negative Myeloproliferative Neoplasms

Assessment of Cell-Free DNA (cfDNA) in 221 Patients with Lymphoproliferative Malignancies at Diagnosis and during Follow-up

High Diagnostic Utility of Flow Cytometry Based Peripheral Blood Monocyte Subset Analysis, CD56 and CD2 Expression in Chronic Myelomonocytic Leukemia (CMML)

Clinical Characteristics and Cardioavscular Events in Patients with Esential Thrombocythemia with <10% Vs. ≥10% JAK2 V617F Allele Burden

Oligomonocytic Chronic Myelomonocytic Leukemia (O-CMML) and Chronic Myelomonocytic Leukemia (CMML) Show Similar Clinical, Morphological, Immunophenotypic and Molecular Features

Molecular Characterization of Ph-Negative Myeloproliferative Neoplasms in Tumor Circulating Nucleic Acids

rs2431697, a Polymorphism of Mir-146a, Is a Precozing Marker of Progression to Secondary Myelofibrosis: New Epigenetic Regulation of Jak/Stat3 Signaling

Acquisition of Non-Driver Mutations during Follow-up in Patients with Polycythemia Vera and Essential Thrombocythemia

Role of Non-Driver Mutations and JAK2 V617F Allele Burden in Myelofibrotic and Acute Myeloid Transformation of Patients with Polycythemia Vera and Essential Thrombocythemia

Potential of Digital PCR in CML Calibration

MYD88 (L265P) Mutation Confers Very Poor Response and Outcome after Second-Line Therapy in Patients with Diffuse Large B-Cell Lymphoma (DLBCL)

Characterization of CD34+ Hematopoietic Progenitor Cells in JAK2 V617F and Calr- mutated Myeloproliferative Neoplasms

JAK2 Exon 12 Mutant Allele Burden Study (JETMABS): A European Multicenter Study

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only